Cargando…
Mucosal Immunization Has Benefits over Traditional Subcutaneous Immunization with Group A Streptococcus Antigens in a Pilot Study in a Mouse Model
Group A Streptococcus (GAS) is a major human pathogen for which there is no licensed vaccine. To protect against infection, a strong systemic and mucosal immune response is likely to be necessary to prevent initial colonization and any events that might lead to invasive disease. A broad immune respo...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674289/ https://www.ncbi.nlm.nih.gov/pubmed/38006056 http://dx.doi.org/10.3390/vaccines11111724 |
_version_ | 1785149692193013760 |
---|---|
author | Shaw, Helen Alexandra Remmington, Alex McKenzie, Giselle Winkel, Caroline Mawas, Fatme |
author_facet | Shaw, Helen Alexandra Remmington, Alex McKenzie, Giselle Winkel, Caroline Mawas, Fatme |
author_sort | Shaw, Helen Alexandra |
collection | PubMed |
description | Group A Streptococcus (GAS) is a major human pathogen for which there is no licensed vaccine. To protect against infection, a strong systemic and mucosal immune response is likely to be necessary to prevent initial colonization and any events that might lead to invasive disease. A broad immune response will be necessary to target the varied GAS serotypes and disease presentations. To this end, we designed a representative panel of recombinant proteins to cover the stages of GAS infection and investigated whether mucosal and systemic immunity could be stimulated by these protein antigens. We immunized mice sublingually, intranasally and subcutaneously, then measured IgG and IgA antibody levels and functional activity through in vitro assays. Our results show that both sublingual and intranasal immunization in the presence of adjuvant induced both systemic IgG and mucosal IgA. Meanwhile, subcutaneous immunization generated only a serum IgG response. The antibodies mediated binding and killing of GAS cells and blocked binding of GAS to HaCaT cells, particularly following intranasal and subcutaneous immunizations. Further, antigen-specific assays revealed that immune sera inhibited cleavage of IL-8 by SpyCEP and IgG by Mac/IdeS. These results demonstrate that mucosal immunization can induce effective systemic and mucosal antibody responses. This finding warrants further investigation and optimization of humoral and cellular responses as a viable alternative to subcutaneous immunization for urgently needed GAS vaccines. |
format | Online Article Text |
id | pubmed-10674289 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106742892023-11-17 Mucosal Immunization Has Benefits over Traditional Subcutaneous Immunization with Group A Streptococcus Antigens in a Pilot Study in a Mouse Model Shaw, Helen Alexandra Remmington, Alex McKenzie, Giselle Winkel, Caroline Mawas, Fatme Vaccines (Basel) Article Group A Streptococcus (GAS) is a major human pathogen for which there is no licensed vaccine. To protect against infection, a strong systemic and mucosal immune response is likely to be necessary to prevent initial colonization and any events that might lead to invasive disease. A broad immune response will be necessary to target the varied GAS serotypes and disease presentations. To this end, we designed a representative panel of recombinant proteins to cover the stages of GAS infection and investigated whether mucosal and systemic immunity could be stimulated by these protein antigens. We immunized mice sublingually, intranasally and subcutaneously, then measured IgG and IgA antibody levels and functional activity through in vitro assays. Our results show that both sublingual and intranasal immunization in the presence of adjuvant induced both systemic IgG and mucosal IgA. Meanwhile, subcutaneous immunization generated only a serum IgG response. The antibodies mediated binding and killing of GAS cells and blocked binding of GAS to HaCaT cells, particularly following intranasal and subcutaneous immunizations. Further, antigen-specific assays revealed that immune sera inhibited cleavage of IL-8 by SpyCEP and IgG by Mac/IdeS. These results demonstrate that mucosal immunization can induce effective systemic and mucosal antibody responses. This finding warrants further investigation and optimization of humoral and cellular responses as a viable alternative to subcutaneous immunization for urgently needed GAS vaccines. MDPI 2023-11-17 /pmc/articles/PMC10674289/ /pubmed/38006056 http://dx.doi.org/10.3390/vaccines11111724 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Shaw, Helen Alexandra Remmington, Alex McKenzie, Giselle Winkel, Caroline Mawas, Fatme Mucosal Immunization Has Benefits over Traditional Subcutaneous Immunization with Group A Streptococcus Antigens in a Pilot Study in a Mouse Model |
title | Mucosal Immunization Has Benefits over Traditional Subcutaneous Immunization with Group A Streptococcus Antigens in a Pilot Study in a Mouse Model |
title_full | Mucosal Immunization Has Benefits over Traditional Subcutaneous Immunization with Group A Streptococcus Antigens in a Pilot Study in a Mouse Model |
title_fullStr | Mucosal Immunization Has Benefits over Traditional Subcutaneous Immunization with Group A Streptococcus Antigens in a Pilot Study in a Mouse Model |
title_full_unstemmed | Mucosal Immunization Has Benefits over Traditional Subcutaneous Immunization with Group A Streptococcus Antigens in a Pilot Study in a Mouse Model |
title_short | Mucosal Immunization Has Benefits over Traditional Subcutaneous Immunization with Group A Streptococcus Antigens in a Pilot Study in a Mouse Model |
title_sort | mucosal immunization has benefits over traditional subcutaneous immunization with group a streptococcus antigens in a pilot study in a mouse model |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674289/ https://www.ncbi.nlm.nih.gov/pubmed/38006056 http://dx.doi.org/10.3390/vaccines11111724 |
work_keys_str_mv | AT shawhelenalexandra mucosalimmunizationhasbenefitsovertraditionalsubcutaneousimmunizationwithgroupastreptococcusantigensinapilotstudyinamousemodel AT remmingtonalex mucosalimmunizationhasbenefitsovertraditionalsubcutaneousimmunizationwithgroupastreptococcusantigensinapilotstudyinamousemodel AT mckenziegiselle mucosalimmunizationhasbenefitsovertraditionalsubcutaneousimmunizationwithgroupastreptococcusantigensinapilotstudyinamousemodel AT winkelcaroline mucosalimmunizationhasbenefitsovertraditionalsubcutaneousimmunizationwithgroupastreptococcusantigensinapilotstudyinamousemodel AT mawasfatme mucosalimmunizationhasbenefitsovertraditionalsubcutaneousimmunizationwithgroupastreptococcusantigensinapilotstudyinamousemodel |